By Elsa Loissel - 11 September 201711/09/17
Imad I. Yassin appointed Vice President of Sales and Marketing for Genestack.
More From Genestack In Lifescience
By Elsa Loissel - 04 August 201704/08/17
Dr Misha Kapushesky, CEO of Genestack, selected for Frost & Sullivan masterclass.
By Rachel Holdsworth - 07 June 201707/06/17
Cambridge Innovation Capital (CIC) has invested as part of a £40 million Series B financing round for Bicycle Therapeutics.
More From Cambridge Innovation Capital In Lifescience
By Elsa Loissel - 23 May 201723/05/17
Genestack allows public and private data to be searched, analysed, visualised in one browser.
By Rachel Holdsworth - 07 February 201707/02/17
Dr Michael Anstey joins Cambridge Innovation Capital with experience in advising multinational healthcare businesses across the world.
By Elsa Loissel - 19 January 201719/01/17
“Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes,”presentation by Congenica at PMWC 2017, January 23.
More From Congenica In Lifescience
By Elsa Loissel - 04 December 201604/12/16
Accurate variant analysis facilitates personalised care pathways
By Elsa Loissel - 20 October 201620/10/16
Congenica's whole genome analysis platform detecting clinically relevant variants in 35% of first diagnostic reports delivered to UK Project.
By Adrian Ient - 18 October 201618/10/16
Congenica’s Dr Matthew Hurles to address the bottlenecks of consistency and data sharing at the ASHG annual meeting on the 20th October 2016
By Elsa Loissel - 24 August 201624/08/16
Mike Furness of Cambridge based genomics analysis company says more clinical input required to ensure consistency.
By Elsa Loissel - 19 August 201619/08/16
Personalised medicine holds the promise of a new approach to healthcare, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
By Elsa Loissel - 29 July 201629/07/16
Workflow and data visualisation features for Congenica's interpretation platform support whole exome sequencing.
By Claire Lynn - 28 June 201628/06/16
Gurdon Institute spin-out gains funding from Imperial Innovations, Cambridge Innovation Capital, Merck Ventures and Pfizer Venture Investments.
By Rachel Holdsworth - 24 June 201624/06/16
Project aims to evaluate exome sequencing for non-invasive prenatal testing.
By Claire Lynn - 02 May 201602/05/16
BWH adopts Congenica’s Sapientia for gene-disease insights that reclassify disease.